2018-05-14T11:17:27-04:00 2017-12-31 382706146 YEO & YEO PC 1450 EISENHOWER PLACE ANN ARBOR MI 481083283 990 2017-01-01 861087705 SARC SARC 7349307600 24 FRANK LLOYD WRIGHT DRIVE RM 3100 ANN ARBOR MI 48106 DENISE REINKE PRESIDENT/CEO 7349307600 2018-05-04 true THOMAS A O'SULLIVAN P01321877 7347691331 2018-05-14 70.34.166.253 2018-05-14 10:17:27 CD P F05E70591467175866F8CD01CFD966A6957D8035 94A0B18387F388711E48F1C280F31DA279B52269 2017 2021-01-29 14:40:06Z DENISE REINKE 24 FRANK LLOYD WRIGHT DR ANN ARBOR MI 48106 3572031 false X WWW.SARCTRIALS.ORG X 2004 MI TO PROVIDE A COLLABORATIVE INFRASTRUCTURE TO MAKE PROGRESS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF SARCOMA. 9 9 19 9 0 1881392 1401787 1670118 2156859 16126 13385 0 3567636 3572031 550000 150000 0 1223871 1050803 0 0 3184763 3318779 4958634 4519582 -1390998 -947551 8346469 7059071 548024 208177 7798445 6850894 X TO PROVIDE A COLLABORATIVE INFRASTRUCTURE TO MAKE PROGRESS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF SARCOMA. false false 1980184 2156859 THE SARCOMA ALLIANCE FOR RESEARCH THROUGH COLLABORATION IS A US-BASED NON- PROFIT SARCOMA RESEARCH COOPERATIVE SOLELY DEDICATED TO FOSTERING PROGRESS IN THE PREVENTION AND TREATMENT OF SARCOMA IN ORDER TO IMPROVE PATIENT OUTCOMES AND ULTIMATELY FIND A CURE. SARC'S UNIQUE ABILITY TO PROMOTE COLLABORATION AND UNITY AMONG THE SARCOMA RESEARCH COMMUNITY THROUGH SCIENTIFIC RIGOR, CREDIBILITY AND EFFICIENCY ENSURES THAT THINGS GET DONE. COLLABORATIVE PARTNERSHIPS AND CONTINUED PROGRESS GENERATE FURTHER INVESTMENT IN SARC'S WORK FOR THE GOOD OF PATIENTS. 150000 150000 SARC CAREER DEVELOPMENT PROGRAM IS TO HELP PREPARE AND SUPPORT CLINICIAN- SCIENTISTS WORKING IN SARCOMA AS THEY BEGIN THEIR CAREERS AS INDEPENDENT CLINICAL RESEARCHERS. THE EARLY STAGE OF CAREER DEVELOPMENT, WHEN A RESEARCHER IS TRANSITIONING FROM WORKING IN A MENTORED ENVIRONMENT TO SETTING UP AN INDEPENDENT RESEARCH PROGRAM AND OBTAINING GRANT FUNDING, IS A CRITICAL PERIOD. IT IS OFTEN MORE DIFFICULT FOR CLINICIAN-SCIENTISTS WHO ARE CONDUCTING CLINICAL RESEARCH TO MAKE THIS TRANSITION THAN IT IS FOR OTHER RESEARCHERS BECAUSE THESE INDIVIDUALS TYPICALLY HAVE TO BALANCE THE DEMANDS OF SEEING PATIENTS WITH THOSE OF CONDUCTING RESEARCH. THOSE DEMANDS, TOGETHER WITH THE COMPLEXITY OF TODAY'S RESEARCH ENVIRONMENT AND THE PACE OF PROGRESS, MAKE IT PARTICULARLY CHALLENGING TO MAINTAIN THE KNOWLEDGE BASE NEEDED TO BE BOTH A CLINICIAN AND A RESEARCHER. NEVERTHELESS, THE ROLE OF THE CLINICIAN-SCIENTIST IN PROVIDING THE BRIDGE BETWEEN THE CLINIC AND THE LABORATORY IS CRITICAL FOR THE TIMELY TRANSLATION OF BASIC RESEARCH FINDINGS INTO THERAPEUTIC APPROACHES. CAREER DEVELOPMENT AWARDS ARE OFFERED AT A LEVEL OF 100,000 PER YEAR FOR TWO YEARS. IT IS SARC'S VISION THAT BY PROVIDING STABLE SUPPORT AT A CRITICAL CAREER JUNCTURE FOR CLINICIAN-SCIENTISTS, THE CAREER DEVELOPMENT AWARD WILL ENCOURAGE PHYSICIANS TO PURSUE CAREERS IN CLINICAL RESEARCH. ALSO, SARC HOPES TO SUPPORT SUCCESSFUL CANDIDATES TO HAVE IMPORTANT CAREERS IN ACADEMIC MEDICINE AND BECOME FUTURE LEADERS OF SARC. 1142836 THE NATIONAL CANCER INSTITUTE (NCI) ESTABLISHED THE SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE (SPORE) TO PROMOTE INTERDISCIPLINARY RESEARCH AND TO HELP RESEARCH FINDINGS MOVE QUICKLY FROM THE LABORATORY TO THE PATIENT. TO EARN A HIGHLY COMPETITIVE NCI SPORE GRANT, INSTITUTIONS MUST DEMONSTRATE A HIGH DEGREE OF COLLABORATION BETWEEN FIRST-RATE SCIENTISTS AND CLINICIANS AND SHOW EXCELLENCE IN TRANSLATIONAL RESEARCH PROJECTS. SARC WAS AWARDED A SARCOMA SPORE BY THE NCI IN 2012. THIS IS THE FIRST SPORE TO BE AWARDED TO TA NONPROFIT CONSORTIUM OF ACADEMIC RESEARCHERS, AND ONLY THE SECOND SARCOMA SPORE EVER TO BE AWARDED. 3273020 true true false false false false false false false false true false false false false false true false false false false false false false false false false false true true false false false false false false false false false false false false false false false false false true 33 0 19 true false false false false false false false false false false false false X 9 9 false false false false false false false true true false false false true true true true true true true false MI X DENISE REINKE 7349307600 24 FRANK LLOYD WRIGHT DR SUITE 3100 ANN ARBOR MI 48106 MCHENRY TICHENOR CHAIR 1.00 X X 0 0 0 RAPHAEL POLLOCK MD PHD SECRETARY 1.00 X X 0 0 0 DEBORAH BUKS DIRECTOR 1.00 X 0 0 0 DOUG ULMAN DIRECTOR 1.00 X 0 0 0 MARK THORNTON MD PHD DIRECTOR 1.00 X 0 0 0 SUSO PLATERO DIRECTOR 1.00 X 0 0 0 SUSAN BRAUN DIRECTOR 1.00 X 0 0 0 TIMOTHY TIMMERMAN DIRECTOR 1.00 X 0 0 0 LEE HELMAN DIRECTOR 1.00 X 0 0 0 DENISE REINKE PRESIDENT/CE 40.00 X 247041 0 0 CORLISS BEARD FINANCE MANA 40.00 X 58996 0 0 306037 1 false true false PROMETRIKA LLC 725 CONCORD AVENUE CAMBRIDGE MA 02138 RESEARCH/TRIALS 128918 NUYENTOMTISHEN AND AOUN PC 2001 COMMONWEALTH BLVD ANN ARBOR MI 48105 LEGAL 122480 2 1292837 108950 1401787 MEDICAL RESEARCH & EDUCATION 621500 2156859 2156859 2156859 13385 13385 3572031 2156859 13385 150000 150000 306037 79053 226984 553560 165822 387738 74990 74990 61610 61610 54606 32764 21842 208475 91949 116526 18250 18250 2868 2868 96205 67378 28827 57899 2363 55536 67472 67472 101286 49489 51797 81644 65462 16182 9553 9553 72087 72087 TRIAL EXPENSE 1892982 1855814 37168 PATIENT EXPENSE 351296 351296 SPORE INSTITUTIONAL FUNDS 260000 260000 SITE EXPENSE 68110 68110 30652 30652 4519582 3273020 1246562 0 216638 3347 7290202 6396936 663518 491331 33656 34554 440197 307294 142455 132903 8346469 7059071 368552 103823 179472 104354 548024 208177 X 5810400 4409435 1988045 2441459 7798445 6850894 8346469 7059071 -947551 X false true X true true true X 4017437 3300686 2001742 1881392 1401787 12603044 4017437 3300686 2001742 1881392 1401787 12603044 12603044 26763 23365 20324 16126 13385 99963 12703007 2156859 0.99210 0.98940 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 176733 46641 130092 263464 260653 2811 132903 3572031 3572031 3572031 4519582 4519582 4519582 true SPORE CAREER DEVELOPMENT 1 100000 SPORE DEVELOPMENTAL RESEA 1 50000 SCHEDULE I, PAGE 1, PART I, LINE 2 UP TO 100,000 OFFERED PER YEAR FOR UP TO TWO YEARS. FUNDS ARE AWARDED AS A ONE-YEAR GRANT, RENEWABLE FOR ADDITIONAL TWO YEARS MAXIMUM. AWARDEE PROVIDES AN ANNUAL PROGRESS REPORT AND MENTOR REPORT THAT ARE REVIEWED BY COMMITTEE ANNUALLY THROUGH RENEWAL AND COMPLETION. X true false X X X X X false false false false false false false false false DENISE REINKE PRESIDENT/CEO 247041 247041 FORM 990, PAGE 2, PART III, LINE 4B IT PARTICULARLY CHALLENGING TO MAINTAIN THE KNOWLEDGE BASE NEEDED TO BE BOTH A CLINICIAN AND A RESEARCHER. NEVERTHELESS, THE ROLE OF THE CLINICIAN-SCIENTIST IN PROVIDING THE BRIDGE BETWEEN THE CLINIC AND THE LABORATORY IS CRITICAL FOR THE TIMELY TRANSLATION OF BASIC RESEARCH FINDINGS INTO THERAPEUTIC APPROACHES. CAREER DEVELOPMENT AWARDS ARE OFFERED AT A LEVEL OF 100,000 PER YEAR FOR TWO YEARS. IT IS SARC'S VISION THAT BY PROVIDING STABLE SUPPORT AT A CRITICAL CAREER JUNCTURE FOR CLINICIAN-SCIENTISTS, THE CAREER DEVELOPMENT AWARD WILL ENCOURAGE PHYSICIANS TO PURSUE CAREERS IN CLINICAL RESEARCH. ALSO, SARC HOPES TO SUPPORT SUCCESSFUL CANDIDATES TO HAVE IMPORTANT CAREERS IN ACADEMIC MEDICINE AND BECOME FUTURE LEADERS OF SARC. FORM 990, PAGE 6, PART VI, LINE 11B THE FINANCE COMMITTEE, THE PRESIDENT AND THE FINANCE MANAGER PERFORM A DETAILED REVIEW. FORM 990, PAGE 6, PART VI, LINE 12C THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS MADE PART OF THE EMPLOYEE'S PERSONNEL MANUAL WHICH IS REQUIRED READING FOR ALL EMPLOYEES, DIRECTORS AND BOARD MEMBERS. FORM 990, PAGE 6, PART VI, LINE 15A LEAD ATTORNEY AND SCIENTIFIC LEADERSHIP WERE CONTRACTED AS INDEPENDENT CONSULTANTS TO PERFORM COMPENSATION STUDIES FOR CERTAIN ORGANIZATION EMPLOYEES. FORM 990, PAGE 6, PART VI, LINE 15B LEAD ATTORNEY AND SCIENTIFIC LEADERSHIP WERE CONTRACTED AS INDEPENDENT CONSULTANTS TO PERFORM COMPENSATION STUDIES FOR CERTAIN ORGANIZATION EMPLOYEES. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON SPECIFIC REQUEST. 990 RELATED FILINGS ARE AVAILABLE ON GUIDESTAR.COM AS PUBLIC INFORMATION.